Enhabit (EHAB) Competitors $7.98 +0.02 (+0.19%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EHAB vs. NHC, VRDN, AHCO, CDNA, AGL, PNTG, AVAH, CSTL, GRAL, and FLGTShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include National HealthCare (NHC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), agilon health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Grail (GRAL), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Enhabit vs. National HealthCare Viridian Therapeutics AdaptHealth CareDx agilon health The Pennant Group Aveanna Healthcare Castle Biosciences Grail Fulgent Genetics Enhabit (NYSE:EHAB) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment. Which has higher valuation and earnings, EHAB or NHC? National HealthCare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.05B0.38-$80.50M-$2.32-3.44National HealthCare$1.14B1.33$66.80M$7.9812.36 Do institutionals and insiders believe in EHAB or NHC? 56.4% of National HealthCare shares are held by institutional investors. 1.9% of Enhabit shares are held by company insiders. Comparatively, 13.8% of National HealthCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is EHAB or NHC more profitable? National HealthCare has a net margin of 10.03% compared to Enhabit's net margin of -11.24%. National HealthCare's return on equity of 6.87% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-11.24% 1.67% 0.80% National HealthCare 10.03%6.87%4.68% Do analysts prefer EHAB or NHC? Enhabit currently has a consensus price target of $8.75, suggesting a potential upside of 9.58%. Given Enhabit's stronger consensus rating and higher probable upside, equities research analysts plainly believe Enhabit is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor EHAB or NHC? Enhabit received 2 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 14.29% of users gave Enhabit an outperform vote. CompanyUnderperformOutperformEnhabitOutperform Votes414.29%Underperform Votes2485.71% National HealthCareOutperform Votes2100.00% Underperform VotesNo Votes Which has more risk and volatility, EHAB or NHC? Enhabit has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Does the media refer more to EHAB or NHC? In the previous week, Enhabit had 2 more articles in the media than National HealthCare. MarketBeat recorded 2 mentions for Enhabit and 0 mentions for National HealthCare. Enhabit's average media sentiment score of 1.14 beat National HealthCare's score of 0.00 indicating that Enhabit is being referred to more favorably in the media. Company Overall Sentiment Enhabit Positive National HealthCare Neutral SummaryNational HealthCare beats Enhabit on 11 of the 18 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitHome health care services IndustryMedical SectorNYSE ExchangeMarket Cap$401.49M$3.09B$5.21B$19.94BDividend YieldN/A0.38%5.13%3.71%P/E Ratio-3.4429.9189.3441.41Price / Sales0.381.261,240.0416.25Price / Cash2.9316.0543.7519.84Price / Book0.573.415.315.76Net Income-$80.50M-$57.02M$122.54M$993.25M7 Day Performance2.50%4.02%0.59%3.12%1 Month Performance4.38%7.46%2.55%4.75%1 Year Performance-21.79%22.85%25.29%18.83% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit2.2922 of 5 stars$7.99+0.2%$8.75+9.6%-21.8%$401.49M$1.05B-3.4410,800Short Interest ↓News CoverageNHCNational HealthCareN/A$97.01+0.2%N/AN/A$1.50B$1.23B12.1612,400VRDNViridian Therapeutics2.0338 of 5 stars$17.77-2.4%$35.70+100.9%-9.8%$1.41B$302,000.00-4.1250AHCOAdaptHealth3.7596 of 5 stars$10.33+1.9%$12.40+20.0%+53.1%$1.39B$3.26B-6.2610,700Short Interest ↓Positive NewsCDNACareDx3.8067 of 5 stars$25.07+6.1%$29.60+18.1%+131.8%$1.34B$312.78M-9.29740Analyst RevisionGap UpHigh Trading VolumeAGLagilon health3.2742 of 5 stars$2.89+18.9%$3.98+37.8%-51.2%$1.19B$5.59B-3.07650PNTGThe Pennant Group4.0807 of 5 stars$26.23+1.6%$36.00+37.2%+74.8%$900.95M$652.30M38.575,791AVAHAveanna Healthcare0.9068 of 5 stars$4.44-1.6%$4.51+1.6%+100.4%$857.92M$1.98B-13.0633,500CSTLCastle Biosciences3.3194 of 5 stars$26.15-13.6%$40.29+54.1%+30.2%$732.38M$311.88M130.76540High Trading VolumeGRALGrail0.3344 of 5 stars$18.57+4.7%$16.00-13.8%N/A$623.97M$117.67M0.001,360Short Interest ↑FLGTFulgent Genetics4.1788 of 5 stars$17.94-2.0%$22.00+22.6%-34.7%$548.73M$277.76M-3.251,010Positive News Related Companies and Tools Related Companies NHC Competitors VRDN Competitors AHCO Competitors CDNA Competitors AGL Competitors PNTG Competitors AVAH Competitors CSTL Competitors GRAL Competitors FLGT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EHAB) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
